Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

223
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atraumatic Compartment Syndrome Presenting As Wrist Drop: A Case Report.

Cureus·2025
Same author

Combining Immersive Simulation with a Collaborative Procedural Training on Local Anesthetic Systemic Toxicity and Fascia Iliaca Compartment Block: A Pilot Study.

The western journal of emergency medicine·2025
Same author

Sentinel Lymph Node Sampling in Robot-Assisted Staging of Endometrial Cancer.

Southern medical journal·2021
Same author

Challenges to Intraoperative Evaluation of Endometrial Cancer.

JSLS : Journal of the Society of Laparoendoscopic Surgeons·2020
Same author

Handedness and the risk of glioma.

Journal of neuro-oncology·2018
Same author

Stability of synthetic cathinones in oral fluid samples.

Forensic science international·2016

Related Experiment Video

Updated: May 5, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.3K

Updating the Carboplatin Hypersensitivity Protocol: Two Case Studies.

Kimberly Ann Stout1, Briana Miller2

  • 1Kimberly Ann Stout.

Clinical Journal of Oncology Nursing
|March 17, 2025
PubMed
Summary
This summary is machine-generated.

A new carboplatin desensitization protocol improves patient tolerance for gynecologic cancer treatment. This updated protocol is safe, effective, and reduces healthcare costs.

Keywords:
carboplatin hypersensitivitydesensitizationplatinum-sensitive ovarian cancer

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.1K

Related Experiment Videos

Last Updated: May 5, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.3K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.1K

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Pharmacy

Background:

  • Carboplatin is a key chemotherapeutic agent for gynecologic cancers.
  • Reexposure to carboplatin can trigger hypersensitivity reactions, posing risks to patients.
  • Existing carboplatin desensitization protocols lacked standardization.

Purpose of the Study:

  • To update an existing carboplatin desensitization protocol.
  • To align the protocol with current best practices.
  • To achieve cost savings through reduced labor and shorter hospital stays.

Main Methods:

  • Implementation of a revised four-bag, four-hour carboplatin desensitization protocol.
  • Retrospective review of five completed desensitization procedures.
  • Assessment of safety and tolerability using Common Terminology Criteria for Adverse Events.

Main Results:

  • Five successful desensitizations were performed for two patients.
  • Each desensitization yielded pharmacy cost savings of $200 ($108 supply, $92 labor).
  • Nursing cost savings approximated $400 per desensitization.

Conclusions:

  • The updated carboplatin desensitization protocol is safe and well-tolerated.
  • The protocol offers significant cost savings for healthcare institutions.
  • Standardization of carboplatin desensitization improves patient management.